Function

Selective Ligands

Agonists

Antagonists

See also

References

External links

Further reading

• Varga G, Bálint A, Burghardt B, D'Amato M (Apr 2004)."Involvement of endogenous CCK and CCK1 receptors in colonic motor function".British Journal of Pharmacology.141 (8):1275–84.doi:10.1038/sj.bjp.0705769.PMC 1574909.PMID 15100163.
• Wang J, Si YM, Liu ZL, Yu L (Jun 2003). "Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease".Pharmacogenetics.13 (6):365–9.doi:10.1097/00008571-200306000-00008.PMID 12777967.
• Miller LJ, Holicky EL, Ulrich CD, Wieben ED (Oct 1995). "Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity".Gastroenterology.109 (4):1375–80.doi:10.1016/0016-5085(95)90601-0.PMID 7557108.
• Huppi K, Siwarski D, Pisegna JR, Wank S (Feb 1995)."Chromosomal localization of the gastric and brain receptors for cholecystokinin (CCKAR and CCKBR) in human and mouse".Genomics.25 (3):727–9.doi:10.1016/0888-7543(95)80018-H.PMC 6736545.PMID 7759110.
• de Weerth A, Pisegna JR, Huppi K, Wank SA (Jul 1993)."Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor".Biochemical and Biophysical Research Communications.194 (2):811–8.doi:10.1006/bbrc.1993.1894.PMID 8343165.
• Ulrich CD, Ferber I, Holicky E, Hadac E, Buell G, Miller LJ (May 1993). "Molecular cloning and functional expression of the human gallbladder cholecystokinin A receptor".Biochemical and Biophysical Research Communications.193 (1):204–11.doi:10.1006/bbrc.1993.1610.PMID 8503909.
• Kennedy K, Gigoux V, Escrieut C, Maigret B, Martinez J, Moroder L, Fréhel D, Gully D, Vaysse N, Fourmy D (Jan 1997)."Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin".The Journal of Biological Chemistry.272 (5):2920–6.doi:10.1074/jbc.272.5.2920.PMID 9006937.
• Inoue H, Iannotti CA, Welling CM, Veile R, Donis-Keller H, Permutt MA (Jun 1997). "Human cholecystokinin type A receptor gene: cytogenetic localization, physical mapping, and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus (NIDDM)".Genomics.42 (2):331–5.doi:10.1006/geno.1997.4749.PMID 9192855.
• Gigoux V, Escrieut C, Silvente-Poirot S, Maigret B, Gouilleux L, Fehrentz JA, Gully D, Moroder L, Vaysse N, Fourmy D (Jun 1998)."Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state".The Journal of Biological Chemistry.273 (23):14380–6.doi:10.1074/jbc.273.23.14380.PMID 9603948.
• Funakoshi A, Fukamizu Y, Miyasaka K (2000). "Mechanism of cholecystokinin-A- receptor antagonist on human pancreatic exocrine secretion. Localization of CCK-A receptor in the human duodenum".Digestion.60 (Suppl 1):75–80.doi:10.1159/000051459.PMID 10026437.S2CID 41117645.
• Gigoux V, Escrieut C, Fehrentz JA, Poirot S, Maigret B, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy D (Jul 1999)."Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin".The Journal of Biological Chemistry.274 (29):20457–64.doi:10.1074/jbc.274.29.20457.PMID 10400673.
• Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz JA, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy AD (Nov 1999)."Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin".Protein Science.8 (11):2347–54.doi:10.1110/ps.8.11.2347.PMC 2144185.PMID 10595537.
• Funakoshi A, Miyasaka K, Matsumoto H, Yamamori S, Takiguchi S, Kataoka K, Takata Y, Matsusue K, Kono A, Shimokata H (Jan 2000)."Gene structure of human cholecystokinin (CCK) type-A receptor: body fat content is related to CCK type-A receptor gene promoter polymorphism".FEBS Letters.466 (2–3):264–6.doi:10.1016/S0014-5793(00)01080-2.PMID 10682840.S2CID 11683500.
• Tachikawa H, Harada S, Kawanishi Y, Okubo T, Shiraishi H (Apr 2000). "Novel polymorphisms of the human cholecystokinin A receptor gene: an association analysis with schizophrenia".American Journal of Medical Genetics.96 (2):141–5.doi:10.1002/(SICI)1096-8628(20000403)96:2<141::AID-AJMG3>3.0.CO;2-R.PMID 10893485.
• Giragossian C, Mierke DF (Apr 2001). "Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin A receptor".Biochemistry.40 (13):3804–9.doi:10.1021/bi002659n.PMID 11300760.
• Schmitz F, Schrader H, Otte J, Schmitz H, Stüber E, Herzig K, Schmidt WE (Sep 2001). "Identification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells".Regulatory Peptides.101 (1–3):25–33.doi:10.1016/S0167-0115(01)00281-6.PMID 11495676.S2CID 22693627.
• Tachikawa H, Harada S, Kawanishi Y, Okubo T, Suzuki T (Sep 2001). "Linked polymorphisms (-333G>T and -286A>G) in the promoter region of the CCK-A receptor gene may be associated with schizophrenia".Psychiatry Research.103 (2–3):147–55.doi:10.1016/S0165-1781(01)00276-1.PMID 11549403.S2CID 24442175.
• Schmitz F, Göke MN, Otte JM, Schrader H, Reimann B, Kruse ML, Siegel EG, Peters J, Herzig KH, Fölsch UR, Schmidt WE (Dec 2001). "Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa".Regulatory Peptides.102 (2–3):101–10.doi:10.1016/S0167-0115(01)00307-X.PMID 11730982.S2CID 42131386.
• Okubo T, Harada S, Higuchi S, Matsushita S (Aug 2002). "Investigation of quantitative trait loci in the CCKAR gene with susceptibility to alcoholism".Alcoholism: Clinical and Experimental Research.26 (8 Suppl):2S –5S.doi:10.1111/j.1530-0277.2002.tb02693.x.PMID 12198366.
• Takata Y, Takeda S, Kawanami T, Takiguchi S, Yoshida Y, Miyasaka K, Funakoshi A (2003). "Promoter analysis of human cholecystokinin type-A receptor gene".Journal of Gastroenterology.37 (10):815–20.doi:10.1007/s005350200135.PMID 12424565.S2CID 35526543.